Please Wait.....
Report
U.S. Clinical Laboratory Tests Market - Industry Outlook & Forecast 2024-2029
Market Report I 2024-02-15 I 186 Pages I Arizton Advisory & Intelligence
The U.S. clinical laboratory tests market was valued at USD 95.89 billion in 2023 and is expected to grow at a CAGR of 2.17% from 2023-2029.
MARKET TRENDS & OPPORTUNITIES
Advances and Integration of Technologies in Clinical Lab Testing
Clinical labs have seen significant advances due to enhanced computer technology. The days of manually performing lab tests have finally been replaced by exact, compact lab instruments offering rapid throughput-the rapidly increasing interest in the total establishment of automated labs noticed in the COVID-19 pandemic. In recent years, the U.S. clinical laboratory tests market has become more advanced by integrating new technologies, such as robotics, AI, Machine Learning, Cloud computing, and other tools for patient data management. One of the leading technology integrations is AI. It is a transformative element in clinical laboratories. It can scour large data sets to understand and identify the patterns and unknown linkage between disease, environmental conditions, and hereditary factors. These innovations led to early detection and public health and advanced personalized medicine.
Telemedicine And Direct-To-Consumer Solutions Will Be the New Opportunities for Clinical Laboratories
The COVID-19 pandemic tremendously transformed clinical laboratory operations. In the wake of the COVID crisis, deep-seated cultural changes were noticed across the US and global clinical labs, and home testing became universal. Patients also expect clinical lab diagnostic testing to shift from traditional collection points (provider's offices, hospitals, and others) to homes and pharmacies.
Hospitals are Integrating with Clinical Laboratories
With the rising demand for clinical testing, hospitals are experiencing a huge burden in the United States, and integrating hospitals with laboratories or established laboratories is an emerging trend. Hospitals are better positioned to deliver the best possible care with advanced laboratories. From healthcare systems in major cities to community hospitals/clinics across the country, every healthcare setting demands lab tests while maintaining the accuracy, quality, and effective result delivery for medical professionals to make timely decisions about patient's health. Integrated laboratories with hospitals are an efficient part of rapid diagnosis. For instance, LabCorp is managing Ascension Hospitals Labs in around ten states of the US. The company offers a broad range of partnership models to healthcare systems and medical professionals to enhance lab services access across the United States.
Increasing Utilization of Clinical Lab Tests
In the U.S., around 14 billion clinical lab tests are performed annually, making them the most used medical benefits. Across the country, more than 75% of clinical decisions are dependent on clinical lab tests. Over the past few years, the demand for clinical lab tests and services has been reflected in increased lab test expenditure nationwide. The Medicare program spent around USD 10 billion on clinical lab tests and witnessed a 17% increase from 2020 to 2021 in the US.
High Demand for Early & Preventive Diagnosis
The awareness of early disease diagnosis and disease prevention in the U.S. is significant compared to the global population. Billions of clinical lab tests are performed annually across the country, which is significantly higher than in other countries. The culture of America (the U.S.) medicine has long supported and believed that early detection, treatment, and prevention are best.
SEGMENTATION INSIGHTS
INSIGHTS BY TEST COMPLEXITY
The specialty test segment is the dominant test complexity segment in the U.S. clinical laboratory tests market 2023. Specialty tests are performed less than routine tests, but the price of specialty tests plays a vital role in segmental revenue growth. In clinical laboratories, more than 30% of lab tests are specialty lab tests. In addition, the increasing support by the government in specialty test development and delivery and insurance coverage accelerates the segmental growth. Furthermore, specialty tests are complex and segmented into moderately complex and highly complex testing. In specialty testing, genetics testing is a rapidly growing sector where the specialty testing segment obtains high revenue growth.
Segmentation by Test Complexity
- Specialty Tests
- Routine Tests
INSIGHTS BY PROVIDERS
The U.S. clinical laboratory tests market by providers is segmented into hospital-based clinical laboratories, independent laboratories, physician office laboratories, and others. The hospital-based laboratories segment accounted for the largest U.S. clinical laboratory tests market share in 2023. In the healthcare sector, hospital-associated laboratories are at the forefront for patients. Hospital settings are the primary contributor to clinical lab services with the potential to deliver lab tests and diagnostics for outpatients and in-patient requirements, as well as walk-in consumers looking to benefit from the facilities' clinical expertise after receiving the results. Further, hospital-based laboratories conduct significant clinical lab tests and commonly perform more tests than other laboratories. There is one trend that hospitals are integrating with medical laboratories in the United States. The majority of hospitals are in demand for integrated labs. Quest Diagnostics and LabCorp are the two leading clinical labs witnessing increasing hospital demand for integration. These emerging trends are expected to deliver revenue growth opportunities.
Segmentation by Providers
- Hospital-based Clinical Laboratory
- Independent Laboratories
- Physician Office Laboratories (PLOS)
- Others
INSIGHTS BY TEST TYPE
The U.S. clinical laboratory tests market by test type is segmented into clinical & immunochemistry, molecular diagnostics, hematology, microbiology & cytology, and toxicology. Clinical and immunochemistry types of clinical lab tests account for a higher market share and dominate other tests. Identifying biomolecules in human specimens in clinical chemistry tests describes health conditions and predicts future disease conditions. In clinical chemistry, the instrumental analysis of blood components. The major tests are enzymology, toxicology, and endocrinology, specialty tests that account for the segment's high revenue growth. In addition, immunochemistry testing is a highly demanding clinical lab test in the US. These tests are performed to identify the antibodies, detect the immune health issue, and determine the organ, tissue, and fluid compatibility during organ transplantation procedures.
Segmentation by Test Complexity
- Specialty Tests
- Routine Tests
VENDOR LANDSCAPE
The U.S. clinical laboratory tests market is highly competitive, with a wide range of hospital-based laboratories, POLs, and independent clinical and anatomical pathology laboratories. The market is intensely competitive, and consolidation will likely continue in the United States. In addition, an increasing number of health system laboratories are expanding their operations and businesses, resulting in greater competition for clinical laboratory testing from physicians within those health systems and unaffiliated physicians in the health system laboratories' service areas. Further, most U.S. clinical laboratory test market companies offer routine or specialized clinical diagnostic testing services or both depending on their scientific expertise, technologies, innovations, and relevant regulations. Based on that, the competitive landscape in the country for the clinical laboratory test market is highly localized and challenging.
Key Company Profiles
- Eurofins Scientific
- Laboratory Corporation of America
- Mayo Clinic Laboratories
- OPKO Health, Inc. (BioReference Health)
- Quest Diagnostics
- Siemens Healthineers
- Sonic Healthcare
Other Prominent Vendors
- Accu Reference Medical Labs
- ARUP Laboratories
- Clinical Reference Laboratory
- DaVita
- Empire City Laboratories
- Fresenius Medical Care
- HealthTrackRx
- Laboratory of Florida
- Millenium Health
- US Speciality Labs
KEY QUESTIONS ANSWERED:
1. How big is the U.S. clinical laboratory tests market?
2. What is the growth rate of the U.S. clinical laboratory tests market?
3. Which provider segment dominates the U.S. clinical laboratory tests market share?
4. What are the significant U.S. clinical laboratory test market trends?
5. Who are the U.S. clinical laboratory test market's key players?
1 SCOPE & COVERAGE
1.1 MARKET DEFINITION
1.1.1 INCLUSIONS
1.1.2 EXCLUSIONS
1.1.3 MARKET ESTIMATION CAVEATS
1.2 SEGMENT COVERED & DEFINITION
1.2.1 MARKET BY TEST COMPLEXITY
1.2.2 MARKEY BY PROVIDERS
1.2.3 MARKET BY TEST TYPE
1.3 MARKET DERIVATION
1.3.1 BASE YEAR
2 PREMIUM INSIGHTS
2.1 OPPORTUNITY POCKETS
2.2 OVERVIEW
2.2.1 MARKET TRENDS & OPPORTUNITIES
2.2.2 MARKET DRIVERS:
3 MARKET AT A GLANCE
4 INTRODUCTION
4.1 OVERVIEW
4.1.1 FEDERAL REGULATORY FOR LABORATORY MEDICINE
4.1.2 IMPACT OF COVID-19 PANDEMIC
5 MARKET OPPORTUNITIES & TRENDS
5.1 ADVANCES AND INTEGRATION OF TECHNOLOGIES IN CLINICAL LAB TESTING
5.2 HOSPITALS INTEGRATED WITH CLINICAL LABORATORIES
5.3 TELEMEDICINE AND DIRECT-TO-CONSUMER SOLUTIONS PROVIDE NEW OPPORTUNITIES
6 MARKET GROWTH ENABLERS
6.1 RAPIDLY GROWING DEMAND FOR GENETIC TESTING
6.2 INCREASE IN UTILIZATION OF CLINICAL LAB TESTS
6.3 HIGH DEMAND FOR EARLY & PREVENTIVE DIAGNOSIS
7 MARKET RESTRAINTS
7.1 COMPLEXITY AND ETHICAL ISSUES WITH LABORATORY TESTS
7.2 INCREASE IN BURDEN OF INAPPROPRIATE CLINICAL LAB TESTING
7.3 PREFERENCE FOR POINT-OF-CARE TESTING CHALLENGES THE UTILIZATION OF CLINICAL LAB TESTS
8 MARKET LANDSCAPE
8.1 MARKET OVERVIEW
8.2 MARKET SIZE & FORECAST
8.3 FIVE FORCES ANALYSIS
8.3.1 THREAT OF NEW ENTRANTS
8.3.2 BARGAINING POWER OF SUPPLIERS
8.3.3 BARGAINING POWER OF BUYERS
8.3.4 THREAT OF SUBSTITUTES
8.3.5 COMPETITIVE RIVALRY
9 TESTS COMPLEXITY
9.1 MARKET SNAPSHOT & GROWTH ENGINE
9.2 MARKET OVERVIEW
9.3 MARKET BY TEST COMPLEXITY
9.4 SPECIALTY TESTS
9.4.1 MARKET OVERVIEW
9.4.2 MARKET SIZE & FORECAST
9.5 ROUTINE TESTS
9.5.1 MARKET OVERVIEW
9.5.2 MARKET SIZE & FORECAST
10 PROVIDERS
10.1 MARKET SNAPSHOT & GROWTH ENGINE
10.2 MARKET OVERVIEW
10.3 MARKET BY PROVIDERS
10.4 HOSPITAL-BASED LABORATORIES
10.4.1 MARKET OVERVIEW
10.4.2 MARKET SIZE & FORECAST
10.5 INDEPENDENT LABORATORIES
10.5.1 MARKET OVERVIEW
10.5.2 MARKET SIZE & FORECAST
10.6 PHYSICIAN OFFICE LABORATORIES (POLS)
10.6.1 MARKET OVERVIEW
10.6.2 MARKET SIZE & FORECAST
10.7 OTHERS
10.7.1 MARKET OVERVIEW
10.7.2 MARKET SIZE & FORECAST
11 TEST TYPE
11.1 MARKET SNAPSHOT & GROWTH ENGINE
11.2 MARKET OVERVIEW
11.3 MARKET BY TEST TYPE
11.4 CLINICAL & IMMUNOCHEMISTRY
11.4.1 MARKET OVERVIEW
11.4.2 MARKET SIZE & FORECAST
11.5 MOLECULAR DIAGNOSTICS
11.5.1 MARKET OVERVIEW
11.5.2 MARKET SIZE & FORECAST
11.6 HEMATOLOGY
11.6.1 MARKET OVERVIEW
11.6.2 MARKET SIZE & FORECAST
11.7 MICROBIOLOGY & CYTOLOGY
11.7.1 MARKET OVERVIEW
11.7.2 MARKET SIZE & FORECAST
11.8 TOXICOLOGY
11.8.1 MARKET OVERVIEW
11.8.2 MARKET SIZE & FORECAST
12 COMPETITIVE LANDSCAPE
12.1 COMPETITION OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.2.1 EUROFINS SCIENTIFIC
12.2.2 LABORATORY CORPORATION OF AMERICA (LABCORP)
12.2.3 MAYO CLINIC LABORATORIES
12.2.4 OPKO HEALTH (BIOREFERENCE HEALTH)
12.2.5 QUEST DIAGNOSTICS
12.2.6 SIEMENS HEALTHINEERS
12.2.7 SONIC HEALTHCARE
13 KEY COMPANY PROFILES
13.1 EUROFINS SCIENTIFIC
13.1.1 BUSINESS OVERVIEW
13.1.2 SERVICE OFFERINGS
13.1.3 KEY STRATEGIES
13.1.4 KEY STRENGTHS
13.1.5 KEY OPPORTUNITIES
13.2 LABORATORY CORPORATION OF AMERICA
13.2.1 BUSINESS OVERVIEW
13.2.2 SERVICE OFFERINGS
13.2.3 KEY STRATEGIES
13.2.4 KEY STRENGTHS
13.2.5 KEY OPPORTUNITIES
13.3 MAYO CLINIC LABORATORIES
13.3.1 BUSINESS OVERVIEW
13.3.2 SERVICE OFFERINGS
13.3.3 KEY STRATEGIES
13.3.4 KEY STRENGTHS
13.3.5 KEY OPPORTUNITIES
13.4 OPKO HEALTH, INC (BIOREFERENCE HEALTH)
13.4.1 BUSINESS OVERVIEW
13.4.2 SERVICE OFFERINGS
13.4.3 KEY STRATEGIES
13.4.4 KEY STRENGTHS
13.4.5 KEY OPPORTUNITIES
13.5 QUEST DIAGNOSTICS
13.5.1 BUSINESS OVERVIEW
13.5.2 SERVICE OFFERINGS
13.5.3 KEY STRATEGIES
13.5.4 KEY STRENGTHS
13.5.5 KEY OPPORTUNITIES
13.6 SIEMENS HEALTHINEERS
13.6.1 BUSINESS OVERVIEW
13.6.2 SERVICE OFFERINGS
13.6.3 KEY STRATEGIES
13.6.4 KEY STRENGTHS
13.6.5 KEY OPPORTUNITIES
13.7 SONIC HEALTHCARE
13.7.1 BUSINESS OVERVIEW
13.7.2 SERVICE OFFERINGS
13.7.3 KEY STRATEGIES
13.7.4 KEY STRENGTHS
13.7.5 KEY OPPORTUNITIES
14 OTHER PROMINENT VENDORS
14.1 ACCU REFERENCE MEDICAL LABS
14.1.1 BUSINESS OVERVIEW
14.1.2 SERVICE OFFERINGS
14.1.3 KEY STRATEGIES
14.1.4 KEY STRENGTHS
14.1.5 KEY OPPORTUNITIES
14.2 ARUP LABORATORIES
14.2.1 BUSINESS OVERVIEW
14.2.2 SERVICE OFFERINGS
14.2.3 KEY STRATEGIES
14.2.4 KEY STRENGTHS
14.2.5 KEY OPPORTUNITIES
14.3 CLINICAL REFERENCE LABORATORY
14.3.1 BUSINESS OVERVIEW
14.3.2 SERVICE OFFERINGS
14.3.3 KEY STRATEGIES
14.3.4 KEY STRENGTHS
14.3.5 KEY OPPORTUNITIES
14.4 DAVITA
14.4.1 BUSINESS OVERVIEW
14.4.2 SERVICE OFFERINGS
14.4.3 KEY STRATEGIES
14.4.4 KEY STRENGTHS
14.4.5 KEY OPPORTUNITIES
14.5 EMPIRE CITY LABORATORIES
14.5.1 BUSINESS OVERVIEW
14.5.2 SERVICE OFFERINGS
14.5.3 KEY STRATEGIES
14.5.4 KEY STRENGTHS
14.5.5 KEY OPPORTUNITIES
14.6 FRESENIUS MEDICAL CARE
14.6.1 BUSINESS OVERVIEW
14.6.2 SERVICE OFFERINGS
14.6.3 KEY STRATEGIES
14.6.4 KEY STRENGTHS
14.6.5 KEY OPPORTUNITIES
14.7 HEALTHTRACKRX
14.7.1 BUSINESS OVERVIEW
14.7.2 SERVICE OFFERINGS
14.7.3 KEY STRATEGIES
14.7.4 KEY STRENGTHS
14.7.5 KEY OPPORTUNITIES
14.8 LABORATORY OF FLORIDA
14.8.1 BUSINESS OVERVIEW
14.8.2 SERVICE OFFERINGS
14.8.3 KEY STRATEGIES
14.8.4 KEY STRENGTHS
14.8.5 KEY OPPORTUNITIES
14.9 MILLENNIUM HEALTH
14.9.1 BUSINESS OVERVIEW
14.9.2 SERVICE OFFERINGS
14.9.3 KEY STRATEGIES
14.9.4 KEY STRENGTHS
14.9.5 KEY OPPORTUNITIES
14.10 US SPECIALTY LABS
14.10.1 BUSINESS OVERVIEW
14.10.2 SERVICE OFFERINGS
14.10.3 KEY STRATEGIES
14.10.4 KEY STRENGTHS
14.10.5 KEY OPPORTUNITIES
15 REPORT SUMMARY
15.1 KEY TAKEAWAYS
15.2 STRATEGIC RECOMMENDATIONS
16 QUANTITATIVE SUMMARY
16.1 MARKET BY TEST COMPLEXITY
16.2 MARKET BY PROVIDERS
16.3 MARKET BY TEST TYPE
17 APPENDIX
17.1 RESEARCH METHODOLOGY
17.2 RESEARCH PROCESS
17.3 REPORT ASSUMPTIONS & CAVEATS
17.3.1 KEY CAVEATS
17.3.2 CURRENCY CONVERSION
17.4 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 OVERVIEW OF US CLINICAL LABORATORY TESTS MARKET 2023-2029
EXHIBIT 3 DYNAMICS OF US CLINICAL LABORATORY TESTS MARKET
EXHIBIT 4 SEGMENTATION OF US CLINICAL LABORATORY TESTS MARKET
EXHIBIT 5 CLINICAL LABORATORY PROCESSES
EXHIBIT 6 IMPORTANCE OF CLINICAL LABORATORY TESTS IN HEALTHCARE
EXHIBIT 7 IMPACT OF ADVANCES AND INTEGRATION OF TECHNOLOGIES IN CLINICAL LAB TESTING
EXHIBIT 8 TECHNOLOGIES INTEGRATED IN CLINICAL LABS
EXHIBIT 9 IMPACT OF HOSPITALS INTEGRATED WITH CLINICAL LABORATORIES
EXHIBIT 10 IMPACT OF TELEMEDICINE & DIRECT-TO-CONSUMER SOLUTIONS PROVIDE NEW OPPORTUNITIES
EXHIBIT 11 ADVANTAGES OF DIRECT-TO-CONSUMER TESTS
EXHIBIT 12 IMPACT OF RAPIDLY GROWING DEMAND FOR GENETIC TESTING
EXHIBIT 13 IMPACT OF INCREASE IN UTILIZATION OF CLINICAL LAB TESTS
EXHIBIT 14 CLINICAL LABORATORY TESTS PERFORMED FROM 2015 TO 2023 IN US (BILLION)
EXHIBIT 15 IMPACT OF HIGH DEMAND FOR EARLY & PREVENTIVE DIAGNOSIS
EXHIBIT 16 THREE PILLARS OF PREVENTIVE HEALTHCARE IN US
EXHIBIT 17 IMPACT OF COMPLEXITY AND ETHICAL ISSUES WITH LABORATORY TESTS
EXHIBIT 18 CLINICAL LABORATORIES & ETHICAL DILEMMAS
EXHIBIT 19 IMPACT OF INCREASE IN BURDEN OF INAPPROPRIATE CLINICAL LAB TESTING
EXHIBIT 20 IMPACT OF PREFERENCE FOR POINT-OF-CARE TESTING CHALLENGES THE UTILIZATION OF CLINICAL LAB TESTS
EXHIBIT 21 US CLINICAL LABORATORY TESTS MARKET 2023-2029: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 22 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023-2029 (% SHARE)
EXHIBIT 23 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023-2029 (% SHARE)
EXHIBIT 24 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023-2029 (% SHARE)
EXHIBIT 25 US CLINICAL LABORATORY TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 26 FIVE FORCES ANALYSIS 2023
EXHIBIT 27 INCREMENTAL GROWTH BY TEST COMPLEXITY 2023 & 2029
EXHIBIT 28 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023-2029
EXHIBIT 29 OVERVIEW OF US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY
EXHIBIT 30 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY: INCREMENTAL GROWTH
EXHIBIT 31 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY: ABSOLUTE GROWTH
EXHIBIT 32 US CLINICAL LABORATORY TESTS MARKET BY SPECIALTY TEST: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 33 US SPECIALTY CLINICAL LABORATORY TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 34 US CLINICAL LABORATORY TESTS MARKET BY ROUTINE TEST: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 35 US ROUTINE CLINICAL LABORATORY TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 36 INCREMENTAL GROWTH BY PROVIDERS SEGMENT 2023 & 2029
EXHIBIT 37 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023-2029
EXHIBIT 38 TYPES OF LABS & TEST VOLUME OF CLINICAL LABS IN US
EXHIBIT 39 OVERVIEW OF US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS
EXHIBIT 40 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 41 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS: ABSOLUTE GROWTH
EXHIBIT 42 US CLINICAL LABORATORY TESTS MARKET BY HOSPITAL-BASED LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 43 US HOSPITAL-BASED CLINICAL LABORATORY TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 44 US CLINICAL LABORATORY TESTS MARKET BY INDEPENDENT LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 45 US INDEPENDENT CLINICAL LABORATORY TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 46 PHYSICIAN OFFICE LABORATORIES OPERATE UNDER VARIOUS SECTIONS
EXHIBIT 47 US CLINICAL LABORATORY TESTS MARKET BY PHYSICIAN OFFICE LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 48 US PHYSICIAN OFFICE CLINICAL LABORATORY TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 49 US CLINICAL LABORATORY TESTS MARKET BY OTHERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 50 US OTHERS CLINICAL LABORATORY TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 51 INCREMENTAL GROWTH BY TEST TYPE 2023 & 2029
EXHIBIT 52 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023-2029
EXHIBIT 53 OVERVIEW OF US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE
EXHIBIT 54 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE: INCREMENTAL GROWTH
EXHIBIT 55 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE: ABSOLUTE GROWTH
EXHIBIT 56 US CLINICAL LABORATORY TESTS MARKET BY CLINICAL & IMMUNOCHEMISTRY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 57 US CLINICAL LABORATORY TESTS MARKET BY CLINICAL & IMMUNOCHEMISTRY 2020-2029 ($ BILLION)
EXHIBIT 58 GENETIC TESTING IN THE US 2023
EXHIBIT 59 US CLINICAL LABORATORY TESTS MARKET BY MOLECULAR DIAGNOSTICS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 60 US CLINICAL LABORATORY TESTS MARKET BY MOLECULAR DIAGNOSTICS 2020-2029 ($ BILLION)
EXHIBIT 61 US CLINICAL LABORATORY TESTS MARKET BY HEMATOLOGY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 62 US HEMATOLOGY CLINICAL LABORATORY TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 63 US CLINICAL LABORATORY TESTS MARKET BY MICROBIOLOGY & CYTOLOGY TESTS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 64 US CLINICAL LABORATORY TESTS MARKET BY MICROBIOLOGY & CYTOLOGY 2020-2029 ($ BILLION)
EXHIBIT 65 APPLICATIONS OF TOXICOLOGY TESTS
EXHIBIT 66 TOXICOLOGY LABORATORIES BY OWNERSHIP IN US 2021
EXHIBIT 67 US CLINICAL LABORATORY TESTS MARKET BY TOXICOLOGY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 68 US CLINICAL LABORATORY TESTS MARKET BY TOXICOLOGY 2020-2029 ($ BILLION)
EXHIBIT 69 CLINICAL LABORATORIES STATISTICS IN US 2023
EXHIBIT 70 QUEST DIAGNOSTICS AND LABCORP IN US MARKET 2023 (% SHARE)
EXHIBIT 71 ANNUAL REVENUE OF EUROFINS SCIENTIFIC 2020-2022 ($ BILLION)
EXHIBIT 72 ANNUAL REVENUE OF LABORATORY CORPORATION OF AMERICA 2020-2022 ($ BILLION)
EXHIBIT 73 ANNUAL REVENUE OF OPKO HEALTH, INC 2020-2022 ($ BILLION)
EXHIBIT 74 ANNUAL REVENUE OF QUEST DIAGNOSTICS 2020-2022 ($ BILLION)
EXHIBIT 75 ANNUAL REVENUE OF SIEMENS HEALTHINEERS 2020-2022 ($ BILLION)
EXHIBIT 76 ANNUAL REVENUE OF DIAGNOSTICS SEGMENT OF SIMENS HEALTHINEERS 2020-2022 ($ BILLION)
EXHIBIT 77 ANNUAL REVENUE OF SONIC HEALTHCARE 2020-2022 ($ BILLION)
EXHIBIT 78 KEY CAVEATS
LIST OF TABLES
TABLE 1 FEDERAL AGENCIES UNDER CLIA ADMINISTRATION & THEIR RESPONSIBILITIES
TABLE 2 HOSPITALS INTEGRATED WITH TWO MAJOR CLINICAL LABS IN US
TABLE 3 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023-2029 ($ BILLION)
TABLE 4 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023-2029 (%)
TABLE 5 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023-2029 ($ BILLION)
TABLE 6 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023-2029 (%)
TABLE 7 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023-2029 ($ BILLION)
TABLE 8 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023-2029 (%)
TABLE 9 APPLICATIONS OF MICROBIOLOGY CLINICAL TESTING
TABLE 10 TYPE OF TOXICOLOGY TESTING PERFORMED BY RESPECTIVE TOXICOLOGY LABORATORIES & OWNERSHIP OF LABS
TABLE 11 EUROFINS SCIENTIFIC: MAJOR SERVICE OFFERINGS
TABLE 12 LABORATORY CORPORATION OF AMERICA: MAJOR SERVICE OFFERINGS
TABLE 13 MAYO CLINIC LABORATORIES: MAJOR SERVICE OFFERINGS
TABLE 14 OPKO HEALTH, INC: MAJOR SERVICE OFFERINGS
TABLE 15 QUEST DIAGNOSTICS: MAJOR SERVICE OFFERINGS
TABLE 16 SIEMENS HEALTHINEERS: MAJOR SERVICE OFFERINGS
TABLE 17 SONIC HEALTHCARE: MAJOR SERVICE OFFERINGS
TABLE 18 ACCU REFERENCE MEDICAL LABS: MAJOR SERVICE OFFERINGS
TABLE 19 ARUP LABORATORIES: MAJOR SERVICE OFFERINGS
TABLE 20 CLINICAL REFERENCE LABORATORY: MAJOR SERVICE OFFERINGS
TABLE 21 DAVITA: MAJOR SERVICE OFFERINGS
TABLE 22 EMPIRE CITY LABORATORIES: MAJOR SERVICE OFFERINGS
TABLE 23 FRESENIUS MEDICAL CARE: MAJOR SERVICE OFFERINGS
TABLE 24 HEALTHTRACKRX: MAJOR SERVICE OFFERINGS
TABLE 25 LABORATORY OF FLORIDA: MAJOR SERVICE OFFERINGS
TABLE 26 MILLENIUM HEALTH: MAJOR SERVICE OFFERINGS
TABLE 27 US SPECIALTY LABS: MAJOR SERVICE OFFERINGS
TABLE 28 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023-2029 ($ BILLION)
TABLE 29 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023-2029 (%)
TABLE 30 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023-2029 ($ BILLION)
TABLE 31 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023-2029 (%)
TABLE 32 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023-2029 ($ BILLION)
TABLE 33 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023-2029 (%)
TABLE 34 CURRENCY CONVERSION 2016?2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security